Showing 759 news articles about Hepatitis C treatment

Filters Content type: Editors' picks Topic: Hepatitis C treatment

Direct-acting antiviral medicines interfere with different steps of the hepatitis C lifecycle. A combination of drugs may be co-formulated into a single pill. Modern treatment typically lasts for two or three months, usually does not cause side-effects and cures more than 95% of treated people.

Hepatitis C treatment

FDA says Vertex promotional material overstates benefits of hepatitis C drug

Editor's pick
Boston Globe
31 May 2012
New & experimental hepatitis C treatment

GSK seeks to expand low-platelet drug Promacta to hepatitis C patients

Editor's pick
MedCity News
31 May 2012
Hepatitis C treatment

HCV patients may be able to delay therapy

Editor's pick
MedPage Today
23 May 2012
Hepatitis C transmission & prevention

Scotland: Quality Indicators for Hepatitis C

Editor's pick
Health Care Improvement Scotland
30 April 2012
Hepatitis C treatment

Liver Fibrosis Tests Predict Mortality in HIV/HCV Coinfected Women

Editor's pick
HIVandHepatitis.com
11 April 2012
New & experimental hepatitis C treatment

What You Don’t Know, You Can Sell: Merck’s Cavalier Attitude Towards the Welfare of HIV/HCV Coinfected Patients

Editor's pick
TAG
10 April 2012
New & experimental hepatitis C treatment

Revised U.S. Guidelines Make Key HIV and Hep C Treatment Recommendations

Editor's pick
AIDSMeds
3 April 2012
New & experimental hepatitis C treatment

Copy of Revised U.S. Guidelines Make Key HIV and Hep C Treatment Recommendations

Editor's pick
Kaiser Daily Global Health Policy Report
3 April 2012
Hepatitis C transmission & prevention

Clearing or Curing Acute HCV Does Not Protect Against Reinfection

Editor's pick
AIDSMeds
27 March 2012
Hepatitis C treatment

NICE recommends Incivo for hepatitis C

Editor's pick
InPharm
20 March 2012
Hepatitis C treatment

Copy of Cholesterol-Reducing Statins, Other Meds to Be Avoided With Hep C Protease Inhibitors

Editor's pick
Kaiser Daily Global Health Policy Report
1 March 2012
Hepatitis C treatment

Cholesterol-Reducing Statins, Other Meds to Be Avoided With Hep C Protease Inhibitors

Editor's pick
AIDSMeds
1 March 2012
New & experimental hepatitis C treatment

European Medicines Agency informs doctors and patients about drug interaction between Victrelis and ritonavir-boosted HIV protease inhibitors

Editor's pick
European Medicines Agency
18 February 2012
Hepatitis C treatment

Copy of Merck Warns of Victrelis and HIV Protease Inhibitor Interactions

Editor's pick
Kaiser Daily Global Health Policy Report
8 February 2012
Hepatitis C treatment

Merck Warns of Victrelis and HIV Protease Inhibitor Interactions

Editor's pick
AIDSMeds
8 February 2012
Drug interactions & pharmacokinetics

Combining HCV Med Boceprevir with Boosted HIV Protease Inhibitors Can Lower Drug Levels

Editor's pick
HIVandHepatitis.com
7 February 2012
Hepatitis C treatment

European Study Does Not See Rapid Long-Term Liver Fibrosis in HIV/HCV Coinfected People

Editor's pick
HIVandHepatitis.com
2 February 2012
Hepatitis C treatment

Alcohol Treatment Boosts Hep C Cure Rates Among Drinkers

Editor's pick
AIDSMeds.com
31 January 2012
Hepatitis C symptoms & diagnosis

France: Is more frequent monitoring for liver cancer among co-infected people needed?

Editor's pick
CATIE
11 January 2012
Hepatitis C treatment

Poor Liver Transplant Outcomes for HIV/HCV Coinfected Patients

Editor's pick
Medscape (requires free registration)
6 December 2011
Hepatitis C treatment

AASLD: Upping Ribavirin Dose Does Not Increase Interferon Effectiveness in HIV/HCV Coinfected Patients

Editor's pick
HIVandHepatitis.com
24 November 2011
Hepatitis & HIV

Hep C deaths outpace HIV; new drugs, services for coinfected

Editor's pick
Bay Area Reporter
23 November 2011
Hepatitis C treatment

Adverse CNS Effects of HCV Treatment Discourage Adherence

Editor's pick
Medscape (requires free registration)
21 November 2011
Hepatitis C treatment

Blood Thinner Reduces Liver Vein Blood Clots, Protects Liver Functioning in People With Cirrhosis

Editor's pick
AIDSMeds
17 November 2011